Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

By J. Dixon, P. Bhathal, N. Hughes, P. O'Brien. Hepatology, 2004

742 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology

View Paper: https://www.semanticscholar.org/paper/19f8cbde15651a6f4ddb49c3dd0f5023ecb21529

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. E. Bugianesi

In Endocrinology, Diabetes and Metabolism

1. C. Day
2. S. Bellentani
3. Nimantha Mark Wilfred de Alwis
4. E. Bugianesi

In Epidemiology

1. C. Day
2. S. Bellentani
3. V. Ratziu
4. Giulio Marchesini
5. H. Cortez‐Pinto
6. Nimantha Mark Wilfred de Alwis
7. E. Bugianesi

Citations in the corpus

• A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease (2005, methodology): “However, the use of use of enzyme levels as surrogate markers is supported by the association of higher aminotransferases with more severe histological findings in cross-sectional studies (4), and by the finding that reduced aminotransferases are associated with improved histology in intervention st”
• A position statement on NAFLD/NASH based on the EASL 2009 special conference. (2010, background): “In some bariatric surgery series massive weight loss has beneficial effects on steatohepatitis [198], and fibrosis [198–200], an overall improvement which was dependent on the correction of”
• Non-alcoholic fatty liver disease: the mist gradually clears. (2008, background): “To date, all studies have shown improvements in metabolic parameters and steatosis with some, but not all, reporting improvements in necroinflammation and fibrosis [65].”